Publications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (1)

2017

  1. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer

    Oncotarget, Vol. 8, Núm. 9, pp. 15789-15801